Re: Kunimoto et al.: Efficacy and safety of abicipar in neovascular age-related macular degeneration: 52-week results of phase 3 randomized controlled study (Ophthalmology. 2020:127:1331–1334)

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Randomized Controlled ◽

Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age‐Related Macular Degeneration

Ophthalmology ◽

10.1016/j.ophtha.2020.11.017 ◽

2020 ◽

Author(s):

Rahul N. Khurana ◽

Derek Kunimoto ◽

Young Hee Yoon ◽

Charles C. Wykoff ◽

Andrew Chang ◽

...

Keyword(s):

Macular Degeneration ◽

Controlled Study ◽

Phase 3 ◽

Randomized Controlled ◽

Age-Related Macular Degeneration: Self-Management and Reduction of Depressive Symptoms in a Randomized, Controlled Study

Journal of the American Geriatrics Society ◽

10.1111/j.1532-5415.2006.00881.x ◽

2006 ◽

Vol 54 (10) ◽

pp. 1557-1562 ◽

Cited By ~ 35

Author(s):

Barbara L. Brody ◽

Anne-Catherine Roch-Levecq ◽

Robert M. Kaplan ◽

Christine Y. Moutier ◽

Stuart I. Brown

Keyword(s):

Depressive Symptoms ◽

Macular Degeneration ◽

Self Management ◽

Controlled Study ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726172849.793530514 ◽

2017 ◽

Author(s):

Michael Singer

Keyword(s):

Macular Degeneration ◽

Antibody Fragment ◽

Controlled Study ◽

Single Chain ◽

Single Chain Antibody ◽

Randomized Controlled ◽

Vegf Inhibitor ◽

Age Related ◽

Single Chain Antibody Fragment

Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: A phase 3, randomized, controlled study

American Heart Journal ◽

10.1016/j.ahj.2008.08.027 ◽

2009 ◽

Vol 157 (1) ◽

pp. 195-203 ◽

Cited By ~ 53

Author(s):

Syed M. Mohiuddin ◽

Carl J. Pepine ◽

Maureen T. Kelly ◽

Susan M. Buttler ◽

Carolyn M. Setze ◽

...

Keyword(s):

Controlled Study ◽

Efficacy And Safety ◽

Fenofibric Acid ◽

Phase 3 ◽

Randomized Controlled ◽

Mixed Dyslipidemia

Efficacy and safety of combined intravitreal injection of triamcinolone acetonide and ranibizumab in age-related macular degeneration: study protocol for a randomized controlled trial

Clinical Trials in Degenerative Diseases ◽

10.4103/2542-3975.222181 ◽

2017 ◽

Vol 2 (4) ◽

pp. 96

Author(s):

Fen Wei ◽

Xiu-lan Xiao

Keyword(s):

Randomized Controlled Trial ◽

Macular Degeneration ◽

Intravitreal Injection ◽

Triamcinolone Acetonide ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Age Related ◽

Degeneration Study

Comparsion of efficacy and safety between conbercept and ranbizumab in neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials

Ophthalmic Research ◽

10.1159/000519815 ◽

2021 ◽

Author(s):

Xue Wang ◽

Chaofeng Yu ◽

Jiasong Yang ◽

Yuzhen Liu ◽

Yali Xu ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Macular Degeneration ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Comparative Efficacy and Safety of Different Therapeutic Regimens of Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration: A Network Meta-Analysis of Randomized Controlled Trials

SSRN Electronic Journal ◽

10.2139/ssrn.3493218 ◽

2019 ◽

Author(s):

Xin-yu Zhao ◽

Er-qian Wang ◽

Sheng-zhi Liu ◽

An-yi Liang ◽

Ruo-an Han ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Macular Degeneration ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976615.793471426 ◽

2013 ◽

Author(s):

David Boyer

Keyword(s):

Macular Degeneration ◽

Efficacy And Safety ◽

Faculty Opinions recommendation of The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718329667.793493244 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Study ◽

Optimization Strategy ◽

Efficacy And Safety ◽

Randomized Controlled

Comparative Efficacy and Safety of 37 Regimens of Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration: A Network Meta-Analysis of Randomized Controlled Trials

SSRN Electronic Journal ◽

10.2139/ssrn.3516129 ◽

2020 ◽

Author(s):

Xin-yu Zhao ◽

Er-qian Wang ◽

Sheng-zhi Liu ◽

Mingyue Luo ◽

Ruo-an Han ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Meta Analysis ◽

Controlled Trials ◽

Vascular Endothelial ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Age Related ◽

Endothelial Growth Factor